Cytokines and Bone Loss in a 5-Year Longitudinal Study—Hormone Replacement Therapy Suppresses Serum Soluble Interleukin-6 Receptor and Increases Interleukin-1-Receptor Antagonist: The Danish Osteoporosis Prevention Study
The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
The proinflammatory cytokines interleukin-1β (IL-1β) and IL-6 may play a central role in the acceleration of postmenopausal bone loss, but observational studies have led to contradictory results. Estrogen-dependent changes in the production of IL-1 receptor antagonist (IL-1ra) and the soluble IL-6 receptor (sIL-6R) potentially modify cytokine bioactivity. We therefore assessed the impact of menopause and hormone replacement therapy (HRT) on cytokines and activity modifiers in serum within a 5-year longitudinal study. One hundred sixty perimenopausal women (age 50.1 ± 2.8 years) were randomized to HRT or no treatment. Serum IL-6 increased with age (r = 0.16; p < 0.05), but cytokines did not correlate with baseline bone mineral density (BMD). HRT led to small increases in IL-1ra (p < 0.001) and IL-6 (p < 0.05), with a decrease in sIL-6R (p < 0.01) and no change in IL-1β. No changes were observed in the control group. IL-1ra was inversely correlated with bone loss at the ultradistal forearm (r = 0.29; p < 0.05) and to a lesser degree at the spine (r = 0.20; p = 0.09). In addition, there was a weak positive correlation between sIL-6R and bone loss at the ultradistal forearm (r = 0.26; p < 0.05). High IL-6 levels were associated with slower bone loss (spine r = 0.31, p < 0.01) and controlling for age did not diminish this association. The percent change in sIL-6R during HRT was correlated with the bone loss at the femoral neck (r = −0.29; p < 0.01) and weakly with bone loss in the spine (r = −0.16; p = 0.17). In conclusion, serum IL-1ra and sIL-6R are influenced by HRT and are associated with the rate of bone loss in perimenopausal women.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Black, D. M., Cummings, S. R., Karpf, D. B., Cauley, J. A., Thompson, D. E., Nevitt, M. C., Bauer, D. C., Genant, H. K., Haskell, W. L., Marcus, R., et al. (1996) · The Lancet · doi:10.1016/s0140-6736(96)07088-2 · Cited by 3,846
Growth hormone deficiency in adulthood and the effects of growth hormone replacement: a review
Carroll, P. V., Christ the members of Growth Hormon, E. R., Bengtsson, B. Å., Carlsson, L., Christiansen, J. S., Clemmons, D., Hintz, R., Ho, K., Laron, Z., Sizonenko, P., et al. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.2.4594 · Cited by 822 · cited 1×
“(45) In the same way, anatomic sites exhibit differences in their response to growth hormone, (46) parethyroid hormone (PTH),((47,48)) and bisphosphonates.”
BackgroundTilg, H., Trehu, E., Atkins, M., Dinarello, C., & Mier, J. (1994) · Blood · doi:10.1182/blood.v83.1.113.113 · Cited by 817
Estrogen, cytokines, and pathogenesis of postmenopausal osteoporosis
Pacifici, R. (1996) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650110802 · Cited by 741
Increased cytokine production in mononuclear cells of healthy elderly people
Fagiolo, U., Cossarizza, A., Scala, E., Fanales‐Belasio, E., Ortolani, C., Cozzi, E., Monti, D., Franceschi, C., & Paganelli, R. (1993) · European Journal of Immunology · doi:10.1002/eji.1830230950 · Cited by 665 · cited 2×
“The IL-6 secretion by mononuclear blood cells increases with age and menopause, (12,13) but despite inhibition in vitro (14,15) the IL-6 production is not lower in women receiving hormonereplacement therapy (HRT).”
BackgroundPacifici, R., Brown, C., Puscheck, E., Friedrich, E., Slatopolsky, E., Maggio, D., McCracken, R., & Avioli, L. V. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.12.5134 · Cited by 555
Defective inflammatory response in interleukin 6-deficient mice.
Fattori, E., Cappelletti, M., Costa, P., Sellitto, C., Cantoni, L., Carelli, M., Faggioni, R., Fantuzzi, G., Ghezzi, P., & Poli, V (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.4.1243 · Cited by 525
The Functional Block of TNF but Not of IL-6 Prevents Bone Loss in Ovariectomized Mice
Kimble, R. B., Bain, S., & Pacifici, R. (1997) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1997.12.6.935 · Cited by 241 · cited 1×
“(39) Estrogens reduce IL-6 produc tion in vitro,((15,40)) but the findings from clinical studies are far from conclusive.”
BackgroundThe effects of menopause on longitudinal bone loss from the spine
Pouilles, J. M., Tremollieres, F., & Ribot, C. (1993) · Calcified Tissue International · doi:10.1007/bf00310195 · Cited by 149
Research works printed but not linked: 47
- Lindsay, 1990, Estrogen treatment of patients with established postmenopausal osteoporosis, Obstet Gynecol, 76, 290
- Moore, 1990, Long-term estrogen replacement therapy in postmenopausal women sustains vertebral bone mineral density, J Bone Miner Res, 5, 659, 10.1002/jbmr.5650050616 · DOI
- Nielsen, 1994, Magnitude and pattern of skeletal response to long term continous and cyclic sequential oestrogen/progestin treatment, Br Obstet Gynaecol, 101, 319, 10.1111/j.1471-0528.1994.tb13618.x · DOI
- Manolagas, 1995, Bone marrow, cytokines and bone remodeling, N Engl J Med, 332, 305, 10.1056/NEJM199502023320506 · DOI · Paper page
- Fuller, 1998, TRANCE is necessary and sufficient for osteoblast-mediated activation of bone resorption in osteoclasts, J Exp Med, 188, 997, 10.1084/jem.188.5.997 · DOI · Paper page
- Jilka, 1998, Cytokines, bone remodelling, and estrogen deficiency: A 1998 update, Bone, 23, 75, 10.1016/S8756-3282(98)00077-5 · DOI · Paper page
- Matsuzaki, 1998, Osteoclast differentiation factor (ODF) induces osteoclast-like cell formation in human peripheral blood mononuclear cell cultures, Biochem Biophys Res Commun, 246, 199, 10.1006/bbrc.1998.8586 · DOI · Paper page
- Eisenberg, 1990, Primary structure and functional expression from complementary DNA of a human interleukin-1 receptor antagonist, Nature, 343, 341, 10.1038/343341a0 · DOI · Paper page
- Tamura, 1993, Soluble interleukin-6 receptor triggers osteoclast formation by interleukin 6, Proc Natl Acad Sci U S A, 90, 11924, 10.1073/pnas.90.24.11924 · DOI · Paper page
- Kania, 1995, Elevated plasma levels of interleukin-6 in postmenopausal women do not correlate with bone density, J Am Geriatr Soc, 43, 236, 10.1111/j.1532-5415.1995.tb07328.x · DOI
- Girasole, 1992, 17 beta-estradiol inhibits interleukin-6 production by bone marrow-derived stromal cells and osteoblasts in vitro: A potential mechanism for the antiosteoporotic effect of estro-gens, J Clin Invest, 89, 883, 10.1172/JCI115668 · DOI · Paper page
- Kassem, 1996, Estrogen inhibits interleukin-6 production and gene expression in a human osteoblastic cell line with high levels of estrogen receptors, J Bone Miner Res, 11, 193, 10.1002/jbmr.5650110208 · DOI
- Kassem, 1996, Cytokine production in the bone marrow microenvironment: Failure to demonstrate estrogen regulation in early postmenopausal women, J Clin Endocrinol Metab, 81, 513
- Cohen-Solal, 1993, Peripheral monocyte culture supernatants of menopausal women can induce bone resorption: involvement of cytokines, J Clin Endocrinol Metab, 77, 1648
- Rogers, 1998, Effects of estrogen therapy of postmenopausal women on cytokines measured in peripheral blood, J Bone Miner Res, 13, 1577, 10.1359/jbmr.1998.13.10.1577 · DOI · Paper page
- Girasole, 1995, Increased serum soluble interleukin-6 receptor levels are induced by ovariectomy, prevented by estrogen replacement and reversed by alendronate administration, J Bone Miner Res, 10, S161
- Chen, 1995, Serum level of soluble interleukin 6 receptor, not interleukin 6, is correlated with bone resorption markers and lumbar bone mineral density after menopause, J Bone Miner Res, 10, M378
- Maruo, 1996, Serum level of soluble interleukin 6 receptor is correlated with the change of bone metabolism during estrogen therapy, J Bone Miner Res, 11, S118
- McKane, 1994, Circulating levels of cytokines that modulate bone resorption: Effects of age and menopause in women, J Bone Miner Res, 9, 1313, 10.1002/jbmr.5650090821 · DOI · Paper page
- Pacifici, 1993, Monocytic secretion of interleukin-1 receptor antagonist in normal and osteoporotic women: Effects of menopause and estrogen/progesterone therapy, J Clin Endocrinol Metab, 77, 1135
- Keating, 1999, Use of hormone replacement therapy by postmenopausal women in the United States, Ann Intern Med, 130, 545, 10.7326/0003-4819-130-7-199904060-00002 · DOI · Paper page
- Brett, 1997, Use of postmenopausal hormone replacement therapy: Estimates from a nationally representative cohort study, Am J Epidemiol, 145, 536, 10.1093/oxfordjournals.aje.a009142 · DOI · Paper page
- Ralston, 1994, Analysis of gene expression in human bone biopsies by polymerase chain reaction: Evidence for enhanced cytokine expression in postmenopausal osteoporosis, J Bone Miner Res, 9, 883, 10.1002/jbmr.5650090614 · DOI · Paper page
- Abrahamsen, 2000, Cytokine RNA levels in transiliac bone biopsies from healthy early postmenopausal women, Bone, 26, 137, 10.1016/S8756-3282(99)00260-4 · DOI
- Cohen Solal, 1998, Increased bone resorbing activity of peripheral monocyte culture supernatants in elderly women, J Clin Endocrinol Metab, 83, 1687, 10.1210/jcem.83.5.4808 · DOI
- Zheng, 1997, Increase in cytokine production (IL-1 beta, IL-6, TNF-alpha but not IFN-gamma, GM-CSF or LIF) by stimulated whole blood cells in postmenopausal osteoporosis, Maturitas, 26, 63, 10.1016/S0378-5122(96)01080-8 · DOI · Paper page
- Salamone, 1998, Cytokine production and bone mineral density at the lumbar spine and femoral neck in premenopausal women, Calcif Tissue Int, 63, 466, 10.1007/s002239900559 · DOI
- Abrahamsen, 1997, Cytokines and T-lymphocyte subsets in healthy postmenopausal women: Estrogen retards bone loss without affecting the release of IL-1 or IL-1ra, Bone, 20, 251, 10.1016/S8756-3282(96)00384-5 · DOI
- Eisenberg, 1991, Interleukin 1 receptor antagonist is a member of the interleukin 1 gene family: Evolution of a cytokine control mechanism, Proc Natl Acad Sci U S A, 88, 5232, 10.1073/pnas.88.12.5232 · DOI · Paper page
- Kitazawa, 1994, Interleukin-1 receptor antagonist and tumor necrosis factor binding protein decrease osteoclast formation and bone resorption in ovariectomized mice, J Clin Invest, 94, 2397, 10.1172/JCI117606 · DOI · Paper page
- Keen, 1998, Allelic variation at the Interleukin-1 receptor antagonist gene is associated with early postmenopausal bone loss at the spine, Bone, 23, 367, 10.1016/S8756-3282(98)00109-4 · DOI
- Leslie, 1994, Increased PGE2 from human monocytes isolated in the luteal phase of the menstrual cycle. Implications for immunity?, Prostaglandins, 47, 41, 10.1016/0090-6980(94)90073-6 · DOI
- Polan, 1990, Cultured human luteal peripheral monocytes secrete increased levels of interleukin-1, J Clin Endocrinol Metab, 70, 480, 10.1210/jcem-70-2-480 · DOI · Paper page
- Jilka, 1992, Increased osteoclast development after estrogen loss: Mediation by interleukin-6, Science, 257, 88, 10.1126/science.1621100 · DOI · Paper page
- Poli, 1994, Interleukin-6 deficient mice are protected from bone loss caused by estrogen depletion, EMBO J., 13, 1189, 10.1002/j.1460-2075.1994.tb06368.x · DOI · Paper page
- Stein, 1995, Repression of the interleukin-6 promoter by estrogen receptor is mediated by NF-kappa B and C/EBP beta, Mol Cell Biol, 15, 4971, 10.1128/MCB.15.9.4971 · DOI · Paper page
- Xing, 1998, IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses, J Clin Invest, 101, 311, 10.1172/JCI1368 · DOI · Paper page
- Abrahamsen, 1997, Site of osteodensitometry in perimenopausal women: Correlation and limits of agreement between anatomic regions, J Bone Miner Res, 12, 1471, 10.1359/jbmr.1997.12.9.1471 · DOI
- Malpe, 1997, Insulin-like growth factor (IGF)-I, -II, IGF binding proteins (IGFBP)-3,−4 and −;5 levels in the conditioned media of normal human bone cells are skeletal site-dependent, J Bone Miner Res, 12, 423, 10.1359/jbmr.1997.12.3.423 · doi:10.1359/jbmr.1997.12.3.423
- Cosman, 1998, Is parathyroid hormone a therapeutic option for osteoporosis?, A review of the clinical evidence. Calcif Tissue Int, 62, 475, 10.1007/s002239900464 · DOI
- Thorsen, 1997, Changes in bone mass and serum markers of bone metabolism after parathyroidectomy, Surgery, 122, 882, 10.1016/S0039-6060(97)90328-7 · doi:10.1016/s0039-6060(97)90328-7
- Munk-Jensen, 1988, Reversal of postmenopausal vertebral bone loss by oestrogen and progestogen: A double blind placebo controlled study, BMJ, 296, 1150, 10.1136/bmj.296.6630.1150 · DOI · Paper page
- Stock, 1989, Effects of estrogen in vivo and in vitro on spontaneous interleukin-1 release by monocytes from postmenopausal women, J Clin Endocrinol Metab, 68, 364, 10.1210/jcem-68-2-364 · DOI · Paper page
- Hustmyer, 1993, Cytokine production and surface antigen expression by peripheral blood mononuclear cells in postmenopausal osteoporosis, J Bone Miner Res, 8, 51, 10.1002/jbmr.5650080108 · DOI · Paper page
- Khosla, 1994, Circulating cytokine levels in osteoporotic and normal women, J Clin Endocrinol Metab, 79, 707
- Hogasen, 1995, There is no difference in spontaneous and 17 beta-estradiol- induced interleukin-1 beta release by peripheral blood mononuclear cells from nonosteoporotic women with different rates of early postmenopausal bone loss, J Clin Endocrinol Metab, 80, 2480
- Cantatore, 1995, Effect of oestrogen replacement on bone metabolism and cytokines in surgical menopause, Clin Rheumatol, 14, 157, 10.1007/BF02214935 · DOI
Cited by
Proinflammatory Cytokines, Aging, and Age-Related Diseases
Michaud, M., Balardy, L., Moulis, G., Gaudin, C., Peyrot, C., Vellas, B., Cesari, M., & Nourhashemi, F. (2013) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2013.05.009 · Cited by 1,094
Changes in Proinflammatory Cytokine Activity after Menopause
Pfeilschifter, J., Köditz, R., Pfohl, M., & Schatz, H. (2002) · Endocrine Reviews · doi:10.1210/edrv.23.1.0456 · Cited by 914
O’Connor, M.-F., Bower, J. E., Cho, H. J., Creswell, J. D., Dimitrov, S., Hamby, M. E., Hoyt, M. A., Martin, J. L., Robles, T. F., Sloan, E. K., et al. (2009) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2009.04.005 · Cited by 500
The role of the immune system in the pathophysiology of osteoporosis
Clowes, J. A., Riggs, B. L., & Khosla, S. (2005) · Immunological Reviews · doi:10.1111/j.0105-2896.2005.00334.x · Cited by 359
Vitamin D and Bone Health; Potential Mechanisms
Laird, E., Ward, M., McSorley, E., Strain, J. J., & Wallace, J. (2010) · Nutrients · doi:10.3390/nu2070693 · Cited by 358
Metadata
- Authors
- Abrahamsen, B., Bonnevie-Nielsen, V., Ebbesen, E. N., Gram, J., & Beck-Nielsen, H.
- Venue
- Journal of Bone and Mineral Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2000-08-01
- Volume
- 15
- Issue
- 8
- Pages
- 1545-1554
- ISSN
- 0884-0431 (ISSN-L)
- 1523-4681
- OpenAlex
- W2048008931
- Cited by
- 90
- References
- 9
- FWCI
- 3.30
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cytokines and Bone Loss in a 5-Year Longitudinal Study—Hormone Replacement Therapy Suppresses Serum Soluble Interleukin-6 Receptor and Increases Interleukin-1-Receptor Antagonist: The Danish Osteoporosis Prevention Study. https://app.cochat.ai/papers/10.1359/jbmr.2000.15.8.1545
- The paper
- Abrahamsen, B., Bonnevie-Nielsen, V., Ebbesen, E. N., Gram, J., & Beck-Nielsen, H. (2000). Cytokines and Bone Loss in a 5-Year Longitudinal Study—Hormone Replacement Therapy Suppresses Serum Soluble Interleukin-6 Receptor and Increases Interleukin-1-Receptor Antagonist: The Danish Osteoporosis Prevention Study. Journal of Bone and Mineral Research. https://doi.org/10.1359/jbmr.2000.15.8.1545
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.